Literature DB >> 29678819

Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy.

Wafa AlDhaleei1, Ayesha AlMarzooqi1, Nouran Gaber1.   

Abstract

Metronidazole is a commonly used antimicrobial worldwide. The most common side effects that have been reported are nausea, vomiting and hypersensitivity reactions. However, neurotoxicity has been reported with the use of metronidazole but rather rare. The most common neurological manifestation is peripheral neuropathy involvement in the form of sensory loss. It is worth mentioning that central neurotoxicity is a rare side effect of metronidazole use but reversible. The manifestations vary from a headache, altered mental status to focal neurological deficits. The diagnosis is mainly by neuroimaging in the setting of acute neurological change in the patient status. Here, we report a case of metronidazole-induced neurotoxicity in a 38-year-old male patient who was admitted with a brain abscess and was started on metronidazole for more than 10 weeks. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  drugs and medicines; neurology (drugs and medicines); radiology (diagnostics)

Mesh:

Substances:

Year:  2018        PMID: 29678819      PMCID: PMC5911128          DOI: 10.1136/bcr-2017-223463

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  IMAGES IN CLINICAL MEDICINE. Metronidazole-Associated Encephalopathy.

Authors:  Dimitrios Farmakiotis; Barry Zeluff
Journal:  N Engl J Med       Date:  2016-04-14       Impact factor: 91.245

2.  Metronidazole-induced combined peripheral and central vestibulopathy.

Authors:  Sun-Uk Lee; Il-Eok Jung; Hyo-Jung Kim; Ji-Soo Kim
Journal:  J Neurol Sci       Date:  2016-03-28       Impact factor: 3.181

3.  [Metronidazole-Induced Encephalopathy during Brain Abscess Treatment:Two Case Reports].

Authors:  Yuka Yokoyama; Katsuyuki Asaoka; Taku Sugiyama; Kazuki Uchida; Daisuke Shimbo; Satoshi Kobayashi; Koji Itamoto
Journal:  No Shinkei Geka       Date:  2015-10

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 5.  Metronidazole-induced central nervous system toxicity: a systematic review.

Authors:  Akira Kuriyama; Jeffrey L Jackson; Asako Doi; Toru Kamiya
Journal:  Clin Neuropharmacol       Date:  2011 Nov-Dec       Impact factor: 1.592

Review 6.  Clinical and Neuroradiological Spectrum of Metronidazole Induced Encephalopathy: Our Experience and the Review of Literature.

Authors:  Ujjawal Roy; Ajay Panwar; Alak Pandit; Susanta Kumar Das; Bhushan Joshi
Journal:  J Clin Diagn Res       Date:  2016-06-01

Review 7.  [Clinical Characteristics of Metronidazole-induced Encephalopathy: A Report of Two Cases and a Review of 32 Japanese Cases in the Literature].

Authors:  Hideaki Kato; Hiroko Sosa; Masaaki Mori; Takeshi Kaneko
Journal:  Kansenshogaku Zasshi       Date:  2015-09

8.  Metronidazole induced cerebellar ataxia.

Authors:  Aditya Hari; B Akshaya Srikanth; G Sriranga Lakshmi
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200

9.  Metronidazole-induced encephalopathy in a patient with infectious colitis: a case report.

Authors:  Hoon Kim; Young Woo Kim; Seoung Rim Kim; Ik Seong Park; Kwang Wook Jo
Journal:  J Med Case Rep       Date:  2011-02-14

10.  Metronidazole-Induced Cerebellar Toxicity.

Authors:  Amit Agarwal; Sangam Kanekar; Shyam Sabat; Krishnamurthy Thamburaj
Journal:  Neurol Int       Date:  2016-04-01
View more
  1 in total

1.  Metronidazole-induced encephalopathy: a systematic review.

Authors:  Caspar Godthaab Sørensen; William Kristian Karlsson; Faisal Mohammad Amin; Mette Lindelof
Journal:  J Neurol       Date:  2018-12-07       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.